Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Lopez

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Cardiovascular and Interventional Radiology|October 6, 2018
Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and SafetyAnnefleur M de Bruijn, Sven-Ole J H Adriaansens, Marieke Smink, et al.
Cell Reports|January 12, 2022
2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneityMeena Kusi, Maryam Zand, Li-Ling Lin, et al.
Journal of Autoimmunity|April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsisAnthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Journal of Crohn'S & Colitis|January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesNanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
JAMA Oncology|September 1, 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical TrialThierry Conroy, Florence Castan, Anthony Lopez, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patientsLieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2012
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel diseaseVéronique Cloché, Anthony Buisson, Fanny Tréchot, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 5, 2023
Atezolizumab plus bevacizumab in advanced hepatocellular carcinoma after treatment failure with multikinase inhibitorsVincent Haghnejad, Marie Muller, Lorraine Blaise, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Cardiovascular and Interventional Radiology|October 6, 2018
Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and SafetyAnnefleur M de Bruijn, Sven-Ole J H Adriaansens, Marieke Smink, et al.
Cell Reports|January 12, 2022
2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneityMeena Kusi, Maryam Zand, Li-Ling Lin, et al.
Journal of Autoimmunity|April 7, 2017
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsisAnthony Lopez, Xavier Mariette, Hervé Bachelez, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Journal of Crohn'S & Colitis|January 3, 2018
Thiopurines in Inflammatory Bowel Disease: New Findings and PerspectivesNanne K H de Boer, Laurent Peyrin-Biroulet, Bindia Jharap, et al.
JAMA Oncology|September 1, 2022
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical TrialThierry Conroy, Florence Castan, Anthony Lopez, et al.
Alimentary Pharmacology & Therapeutics|April 2, 2019
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patientsLieven Pouillon, Silvio Danese, Ailsa Hart, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2012
Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel diseaseVéronique Cloché, Anthony Buisson, Fanny Tréchot, et al.
Pageof 7